S3 E12 - Found-A-Yo Self a GLP-1 Pill

<p>This week on <em>The Heavy Truth</em>, Ben and Amy crack open the biggest obesity medicine news since someone looked at a weekly injection and said, &quot;There has to be an easier way.&quot;</p><p>Enter <strong>Foundayo™ (orforglipron)</strong> — Eli Lilly&#39;s brand-new oral GLP-1 weight loss pill. No needles. No refrigeration. No timing your breakfast like you&#39;re defusing a bomb. Just a once-daily tablet that can be taken anytime, with or without food or water. </p><p>Ben and Amy break down:</p><ul><li>What exactly Foundayo is and how it works</li><li>Why this isn&#39;t &quot;Ozempic in a pill&quot;</li><li>The surprising science behind a GLP-1 tablet that doesn&#39;t require fasting</li><li>The ATTAIN-1 trial results, where patients lost an average of about <strong>12.4% of their body weight</strong>, with some losing considerably more. </li><li>How it compares to injectable medications like Zepbound and Wegovy</li><li>Common side effects and who may be a good candidate</li><li>The pricing, insurance questions, and whether this could finally make obesity treatment more accessible to millions of people who never wanted an injection. </li></ul><p>Plus, Ben and Amy discuss the real question everyone&#39;s asking:</p><p><strong>If a GLP-1 shot becomes a GLP-1 pill, does your medicine cabinet officially become a weight-loss pharmacy?</strong></p><p>Whether you&#39;re needle-phobic, GLP-curious, or just wondering if &quot;Foundayo&quot; sounds more like a dance move than a medication, this episode delivers everything you need to know about the newest player in the obesity treatment game.</p><p><strong>Spoiler Alert:</strong> The future of weight management may fit in your pocket.</p><p><em>&quot;Take one tablet daily. Side effects may include reduced hunger, increased hope, and suddenly noticing how many commercials feature pizza.&quot;</em> 🍕💊</p><p>#TheHeavyTruth #Foundayo #Orforglipron #GLP1 #WeightLoss #ObesityMedicine #Lilly #BenAndAmy #NoNeedlesNeeded</p><p></p>